Marks Another Successful Exit for New Water's Inaugural Fund BOCA RATON, Fla. , Aug. 7, 2024 /PRNewswire/ -- New Water Capital (New Water) announced today the completion of the sale of Trillium Health Care Products (Trillium), a leading contract development and manufacturing organization (CDMO) of branded over-the-counter (OTC) products in North America , to Avista Healthcare Partners (Avista).
Transaction terms were not disclosed. Based in Brockville, Ontario , Trillium is a trusted partner to leading North American and global consumer healthcare and pharmaceutical companies. Trillium is a differentiated development and manufacturing partner given its OTC specialization, technical expertise, formulation capabilities, and 30-plus year track record for quality, service, and regulatory compliance.
The company offers broad development and manufacturing capabilities across liquid, semi-solid, and solid dosage forms, with extensive experience in the largest therapeutic categories, such as cough and cold, dermatology, gastrointestinal, allergy, and dietary supplements. "New Water worked with management over our investment period to transform Trillium into a best-in-class, full-service CDMO with an outstanding reputation in the industry," said Jason Neimark , Managing Partner at New Water. "We appreciate all the hard work and investment by the New Water and Trillium teams to position Trillium for rapid future growth.
" Nathan Douglas , Vice President at New Water stated, "Trillium's .